Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501–9.
Article
CAS
PubMed
Google Scholar
Yin WH, Chen JW, Feng AN, Lin SJ, Young S. Multimarker approach to risk stratification among patients with advanced chronic heart failure. Clin Cardiol. 2007;30(8):397–402.
Article
PubMed
Google Scholar
Damman P, Beijk MA, Kuijt WJ, Verouden NJ, van Geloven N, Henriques JP, et al. Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2011;57(1):29–36.
Article
CAS
PubMed
Google Scholar
Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725–35.
Article
PubMed
Google Scholar
Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med. 2001;39(7):571–88.
Article
CAS
PubMed
Google Scholar
de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345(14):1014–21.
Article
PubMed
Google Scholar
Pfister R, Tan D, Thekkanal J, Hellmich M, Schneider CA. NT-pro-BNP is associated with long-term outcome in a heterogeneous sample of cardiac inpatients. Eur J Intern Med. 2007;18(3):215–20.
Article
CAS
PubMed
Google Scholar
Grabowski M, Filipiak KJ, Malek LA, Karpinski G, Huczek Z, Stolarz P, et al. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Int J Cardiol. 2007;115(3):386–90.
Article
PubMed
Google Scholar
Gegenhuber A, Mueller T, Dieplinger B, Poelz W, Pacher R, Haltmayer M. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure. Clin Chim Acta. 2006;370(1–2):174–9.
Article
CAS
PubMed
Google Scholar
Hammerer-Lercher A, Neubauer E, Muller S, Pachinger O, Puschendorf B, Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta. 2001;310(2):193–7.
Article
CAS
PubMed
Google Scholar
Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, von Scheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol. 2001;38(7):1934–41.
Article
CAS
PubMed
Google Scholar
Biondi B. Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur J Endocrinol. 2012;167(5):609–18.
Article
CAS
PubMed
Google Scholar
Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, Mariani F, et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med. 2007;167(14):1526–32.
Article
PubMed
Google Scholar
Ascheim DD, Hryniewicz K. Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. Thyroid. 2002;12(6):511–5.
Article
CAS
PubMed
Google Scholar
Zhang B, Peng W, Wang C, Li W, Xu Y. A low fT3 level as a prognostic marker in patients with acute myocardial infarctions. Internal Med (Tokyo, Japan). 2012;51(21):3009–15.
Article
CAS
Google Scholar
Kimura T, Kanda T, Kotajima N, Kuwabara A, Fukumura Y, Kobayashi I. Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction. Eur J Endocrinol. 2000;143(2):179–84.
Article
CAS
PubMed
Google Scholar
Friberg L, Werner S, Eggertsen G, Ahnve S. Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? Arch Intern Med. 2002;162(12):1388–94.
Article
CAS
PubMed
Google Scholar
Pingitore A, Landi P, Taddei MC, Ripoli A, L’Abbate A, Iervasi G. Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med. 2005;118(2):132–6.
Article
CAS
PubMed
Google Scholar
Shanoudy H, Soliman A, Moe S, Hadian D, Veldhuis JD, Iranmanesh A, et al. Early manifestations of “sick euthyroid” syndrome in patients with compensated chronic heart failure. J Card Fail. 2001;7(2):146–52.
Article
CAS
PubMed
Google Scholar
Passino C, Pingitore A, Landi P, Fontana M, Zyw L, Clerico A, et al. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure. J Card Fail. 2009;15(1):35–40.
Article
CAS
PubMed
Google Scholar
Nessler J, Nessler B, Golebiowska-Wiatrak R, Palka I, Gackowski A, Kitlinski M, et al. Serum biomarkers and clinical outcomes in heart failure patients treated de novo with carvedilol. Cardiol J. 2013;20(2):144–51.
Article
PubMed
Google Scholar
Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 2003;108(19):2317–22.
Article
CAS
PubMed
Google Scholar
Pannitteri G, Marino B, Campa PP, Martucci R, Testa U, Peschle C. Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction. Am J Cardiol. 1997;80(5):622–5.
Article
CAS
PubMed
Google Scholar
Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation. 2001;104(7):746–9.
Article
CAS
PubMed
Google Scholar
Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94(12):1543–53.
Article
CAS
PubMed
Google Scholar
Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM. Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab. 1993;77(6):1695–9.
CAS
PubMed
Google Scholar
Stouthard JM, van der Poll T, Endert E, Bakker PJ, Veenhof CH, Sauerwein HP, et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab. 1994;79(5):1342–6.
CAS
PubMed
Google Scholar
Bartalena L, Bogazzi F, Brogioni S, Grasso L, Martino E. Role of cytokines in the pathogenesis of the euthyroid sick syndrome. Eur J Endocrinol. 1998;138(6):603–14.
Article
CAS
PubMed
Google Scholar
Lubrano V, Pingitore A, Carpi A, Iervasi G. Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure. Biomed Pharmacother. 2010;64(3):165–9.
Article
CAS
PubMed
Google Scholar
Osman R, L’Allier PL, Elgharib N, Tardif JC. Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vasc Health Risk Manag. 2006;2(3):221–37.
Article
PubMed Central
CAS
PubMed
Google Scholar
Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569–619.
Article
CAS
PubMed
Google Scholar
Piepoli MF, Corra U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010;17(1):1–17.
Article
PubMed
Google Scholar
Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.
Article
PubMed
Google Scholar
Burkauskas J, Mickuviene N, Brozaitiene J, Staniute M, Podlipskyte A, Rastenyte D, et al. Gene-environment interactions connecting Low triiodothyronine syndrome and outcomes of cardiovascular disease (GET-VASC): study protocol. Biological Psychiatry and Psychopharmacology. 2014;16(2):66–73.
Google Scholar
Staniute M, Brozaitiene J, Burkauskas J, Kazukauskiene N, Mickuviene N, Bunevicius R. Type D personality, mental distress, social support and health-related quality of life in coronary artery disease patients with heart failure: a longitudinal observational study. Health Qual Life Outcomes. 2015;13:1.
Article
PubMed Central
PubMed
Google Scholar
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.
Article
CAS
PubMed
Google Scholar
Pfister R, Strack N, Wielckens K, Malchau G, Erdmann E, Schneider CA. The relationship and prognostic impact of low-T3 syndrome and NT-pro-BNP in cardiovascular patients. Int J Cardiol. 2010;144(2):187–90.
Article
PubMed
Google Scholar
Mayer Jr O, Simon J, Cech J, Rosolova H, Hrbkova J, Pikner R, et al. Even mild changes in free thyroxine could influence the degree of heart failure measured by its biological surrogates. Physiol Res. 2008;57(4):525–9.
CAS
PubMed
Google Scholar
Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003;107(5):708–13.
Article
PubMed
Google Scholar
Friberg L, Drvota V, Bjelak AH, Eggertsen G, Ahnve S. Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction. Am J Med. 2001;111(9):699–703.
Article
CAS
PubMed
Google Scholar
Chuang CP, Jong YS, Wu CY, Lo HM. Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure. Am J Cardiol. 2014;113(5):845–50.
Article
CAS
PubMed
Google Scholar
Selvaraj S, Klein I, Danzi S, Akhter N, Bonow RO, Shah SJ. Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction. Am J Cardiol. 2012;110(2):234–9.
Article
PubMed Central
CAS
PubMed
Google Scholar
Opasich C, Pacini F, Ambrosino N, Riccardi PG, Febo O, Ferrari R, et al. Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J. 1996;17(12):1860–6.
Article
CAS
PubMed
Google Scholar
Coceani M, Iervasi G, Pingitore A, Carpeggiani C, L’Abbate A. Thyroid hormone and coronary artery disease: from clinical correlations to prognostic implications. Clin Cardiol. 2009;32(7):380–5.
Article
PubMed
Google Scholar
Kozdag G, Ural D, Vural A, Agacdiken A, Kahraman G, Sahin T, et al. Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy. Eur J Heart Fail. 2005;7(1):113–8.
Article
CAS
PubMed
Google Scholar
Peeters RP, Wouters PJ, van Toor H, Kaptein E, Visser TJ, Van den Berghe G. Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab. 2005;90(8):4559–65.
Article
CAS
PubMed
Google Scholar
Pingitore A, Iervasi G, Barison A, Prontera C, Pratali L, Emdin M, et al. Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction. J Card Fail. 2006;12(7):520–6.
Article
CAS
PubMed
Google Scholar
Li X, Chen C, Gan F, Wang Y, Ding L, Hua W. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study. BMC Cardiovasc Disord. 2014;14:67.
Article
PubMed Central
PubMed
Google Scholar
Hawkes AL, Patrao TA, Ware R, Atherton JJ, Taylor CB, Oldenburg BF. Predictors of physical and mental health-related quality of life outcomes among myocardial infarction patients. BMC Cardiovasc Disord. 2013;13:69.
Article
PubMed Central
PubMed
Google Scholar
Leon de la Fuente R, Naesgaard PA, Nilsen ST, Woie L, Aarsland T, Gallo P, et al. B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina. BMC Cardiovasc Disord. 2011;11:57.
Article
PubMed Central
PubMed
Google Scholar
Jung CH, Rhee EJ, Shin HS, Jo SK, Won JC, Park CY, et al. Higher serum free thyroxine levels are associated with coronary artery disease. Endocr J. 2008;55(5):819–26.
Article
CAS
PubMed
Google Scholar
Popelova JR, Kotaska K, Tomkova M, Tomek J. Usefulness of N-terminal Pro-brain natriuretic peptide to predict mortality in adults with congenital heart disease. Am J Cardiol. 2015;116(9):1425–30.
Article
CAS
PubMed
Google Scholar
Wei G, Yaqi R, Ningfu W, Xuwei H. N-terminal prohormone B-type natriuretic peptide and cardiovascular risk in stable coronary artery disease: a meta-analysis of nine prospective studies. Rev Cardiovasc Med. 2013;14(2–4):e92–8.
PubMed
Google Scholar